Expand NEO Menu
NEO MENU

NEO Latest Press Releases

-- June 25, 2026 --

NeoGenomics Appoints Carolyn Starrett to its Board of Directors Business Wire 7:05 AM

-- June 17, 2026 --

NeoGenomics Announces Pricing of Offering of $275 Million Convertible Senior Notes Business Wire 6:00 AM

-- June 15, 2026 --

NeoGenomics Announces Proposed Offering of $275 Million Convertible Senior Notes Business Wire 5:24 PM

-- May 26, 2026 --

NeoGenomics to Present New Research at ASCO Annual Meeting 2026 Business Wire 7:05 AM

-- May 15, 2026 --

NeoGenomics to Participate in Upcoming Investor Conferences Business Wire 9:05 AM

-- April 28, 2026 --

NeoGenomics Reports First Quarter 2026 Results Business Wire 4:05 PM

-- April 23, 2026 --

NeoGenomics Expands Access to Full Oncology Testing Portfolio Through Epic Aura Integration Business Wire 7:05 AM

-- April 13, 2026 --

NeoGenomics to Present Multiple Abstracts Showcasing New Research at AACR Annual Meeting 2026 Business Wire 7:05 AM

-- April 7, 2026 --

NeoGenomics to Report First Quarter 2026 Financial Results on April 28, 2026 Business Wire 7:05 AM

-- March 16, 2026 --

NeoGenomics' PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling Business Wire 7:05 AM

-- February 25, 2026 --

NeoGenomics Launches RaDaR ST, Expanding Molecular Residual Disease Testing Across Multiple Solid Tumor Types Business Wire 7:05 AM

-- February 18, 2026 --

NeoGenomics to Participate in Upcoming Investor Conferences Business Wire 7:05 AM

-- February 17, 2026 --

NeoGenomics Reports Fourth Quarter and Full Year 2025 Results Business Wire 7:05 AM

-- February 12, 2026 --

NeoGenomics Introduces PanTracer Pro to Support Timely, Informed Solid Tumor Therapy Selection Business Wire 7:05 AM
Market Data Delayed 15 Minutes